Back
Crane Vs. Neurogene Industry Stock Comparison
Buy
84
CR
Crane
Last Price:
175.10
Seasonality Move:
6.89%
Sell
5
NGNE
Neurogene
Last Price:
39.96
Seasonality Move:
50.43%
Buy
84
Crane (CR)
is a Buy
Is Crane a Buy, Sell or Hold?
- The current Crane [CR] share price is $175.95. The Score for CR is 84, which is 68% above its historic median score of 50, and infers lower risk than normal.
- CR is currently trading in the 80-90% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk levels may be considerably lower than normal.
Sell
5
Neurogene (NGNE)
is a Sell
Is Neurogene a Buy, Sell or Hold?
- The current Neurogene [NGNE] share price is $39.54. The Score for NGNE is 5, which is 90% below its historic median score of 50, and infers higher risk than normal.
- NGNE is currently trading in the 0-10% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
CR Stock Price Chart
CR Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 5.73 | Buy |
Relative Strength Index (14 RSI): | 67.22 | Buy |
Chaikin Money Flow: | -159466 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (152.51 - 170.75) | Buy |
Bollinger Bands (100): | (145.38 - 161.54) | Buy |
NGNE Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 2.3 | Buy |
Relative Strength Index (14 RSI): | 39.1 | Sell |
Chaikin Money Flow: | -346626 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (43.29 - 61.53) | Sell |
Bollinger Bands (100): | (34.11 - 50.51) | Sell |
CR Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 173.11 | Buy |
20-day SMA: | 162.63 | Buy |
50-day SMA: | 157.47 | Buy |
200-day SMA: | 144.41 | Buy |
8-day EMA: | 172.68 | Buy |
20-day EMA: | 165.95 | Buy |
50-day EMA: | 159.59 | Buy |
200-day EMA: | 142.58 | Buy |
NGNE Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 60.39 | Sell |
20-day SMA: | 53.17 | Sell |
50-day SMA: | 46.66 | Sell |
200-day SMA: | 38.93 | Buy |
8-day EMA: | 54.03 | Sell |
20-day EMA: | 53.18 | Sell |
50-day EMA: | 48.36 | Sell |
200-day EMA: | 38.47 | Buy |
Crane Earnings Growth & CR Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.35 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.96 per share, and an increase next year of $0.73 per share.
Neurogene Earnings Growth & NGNE Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.90 per share.
Crane Technical Analysis
Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | |
---|---|---|---|---|---|---|---|---|---|---|
Oct | Nov | |||||||||
31 | 01 | 04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Neurogene Technical Analysis
Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | |
---|---|---|---|---|---|---|---|---|---|---|
Oct | Nov | |||||||||
31 | 01 | 04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |